Close but you’re still wrong.
Business Development:
HIV Expansion
Account Management:
Kite/Oncology
Specialty Rep:
Liver & maybe HIV Treatment
Primary Care:
PrEP
Business Development reps operate at a higher level of influence than Account Management Oncology because BD isn’t just influencing treatment decisions, they’re creating them.
Account Management reps engage physicians who are already trained to treat aggressively. The demand exists. The clinical mindset to treat, is already there. The only challenge is medication differentiation, not behavior change.
Business Development reps face a much harder mission:
1. Turning non-treaters into treaters
2. Changing clinical behavior where no action was previously taken
3. Building prescriber belief from the ground up
This requires a mastery of clinical education, influence & objection handling, within IDNs, Hospital owned Physician Practices/Hospital Pharmacy Pull Through & large/complex independent group practices in markets with high resistance.
Oncology reps, although highly trained, have expertise in account management & competitive positioning. Valuable, yes, but not easily transferable to roles that require building demand from zero.
Bottom line:
Oncology reps build market share, Business Development reps build new markets